OpenAlex
PricingAboutJobs
Log inGet started
Work

The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant

HTML

Year: 2021
Type: review
Source: Pulmonary Pharmacology & Therapeutics
DOI: 10.1016/j.pupt.2021.102030
Authors: Chris Brightling, Swarupa Kulkarni, Bart N. Lambrecht, David Sandham, Markus Weiss, Pablo Altman
Institutions: University of Leicester, NIHR Leicester Biomedical Research Centre, Erasmus MC, Ghent University, VIB-UGent Center for Inflammation Research, Novartis (Switzerland), Novartis Institutes for BioMedical Research
Language: English

Topic: Asthma and respiratory diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: fevipiprant, prostaglandin D2 receptor, asthma, drug metabolism, drug-drug interactions, pharmacogenetics, sputum eosinophilia, lung function
SDG: Good health and well-being

Open Access status: green

Funder: Novartis Pharma
OpenAlex ID: W3142931815
FWCI: 0.327
Cites: 80
Cited by: 13
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security